Evidence map›Paper›PMID 20886097›Full record

ArticlePLoS pathogens2010

CpG-methylation regulates a class of Epstein-Barr virus promoters.

Martin Bergbauer, Markus Kalla, Anne Schmeinck, Christine Göbel, Ulrich Rothbauer, Sebastian Eck, Anna Benet-Pagès, Tim M Strom, Wolfgang Hammerschmidt

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Arginine Metabolism SupportsbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. The GC% landscape of the Nucleocytoviricota.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Epigenetic control of the Epstein-Barr lifecycle.Current opinion in virology · 2022
    Review
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Martin BergbauerDepartment of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.
Markus Kalla
Anne Schmeinck
Christine Göbel
Ulrich Rothbauer
Sebastian Eck
Anna Benet-Pagès
Tim M Strom
Wolfgang Hammerschmidt
Helmholtz Zentrum München · DELudwig-Maximilians-Universität München · DE

Funding

Genetic Analysis of EBV's Immortalizing GenesR01CA070723 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1996 to 2017
$4.6M
NCI NIH HHS CA70723NCI NIH HHS R01 CA070723
6 · The paper itself

Abstract

DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian gene regulation. In general, cytosine-phosphatidyl-guanosine (CpG)-methylated promoters are transcriptionally repressed and nuclear proteins such as MECP2, MBD1, MBD2, and MBD4 bind CpG-methylated DNA and contribute to epigenetic silencing. Methylation of viral DNA also regulates gene expression of Epstein-Barr virus (EBV), which is a model of herpes virus latency. In latently infected human B cells, the viral DNA is CpG-methylated, the majority of viral genes is repressed and virus synthesis is therefore abrogated. EBV's BZLF1 encodes a transcription factor of the AP-1 family (Zta) and is the master gene to overcome viral gene repression. In a genome-wide screen, we now identify and characterize those viral genes, which Zta regulates. Among them are genes essential for EBV's lytic phase, which paradoxically depend on strictly CpG-methylated promoters for their Zta-induced expression. We identified novel DNA recognition motifs, termed meZRE (methyl-Zta-responsive element), which Zta selectively binds in order to 'read' DNA in a methylation- and sequence-dependent manner unlike any other known protein. Zta is a homodimer but its binding characteristics to meZREs suggest a sequential, non-palindromic and bipartite DNA recognition element, which confers superior DNA binding compared to CpG-free ZREs. Our findings indicate that Zta has evolved to transactivate cytosine-methylated, hence repressed, silent promoters as a rule to overcome epigenetic silencing.

Indexed as

DNA MethylationEpigenesis, GeneticGene Expression Regulation, ViralBlotting, WesternB-LymphocytesCells, CulturedChromatin ImmunoprecipitationCpG IslandsDNA, ViralElectrophoretic Mobility Shift AssayEpstein-Barr Virus InfectionsGenes, ViralHerpesvirus 4, HumanHumansImmunoprecipitationKidneyBZLF1 protein, Herpesvirus 4, HumanDNA, ViralLuciferasesRNA, MessengerTrans-ActivatorsTranscription Factor AP-1

Identifiers

PMID20886097
PMCPMC2944802
OpenAlexW2003063544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.